Much like COVID-19 vaccines, the Centre has now discontinued allocation of Remdesivir to states. Minister of State for Chemical and Fertilizers Mansukh Mandaviya on Saturday took to Twitter explaining that daily production had increased tenfold, with supply now exceeding the demand for the drug.
The Union Minister said that the Centre has decided to procure 50 lakh vials of Remdesivir to maintain it as a strategic stock. At the same time, production had increased from from 33,000 vials per day to 3,50,000 vials per day as the number of plants producing Remdesivir increased from just 20 to 60 within a month.
"I am delighted and satisfied to inform you all that the Production of Remdesivir is ramped up ten times from just ~33,000 vials/day on 11th April 2021 to ~ 3,50,000 vials/day today under the astute leadership of Hon'ble PM Shri @narendramodi Ji," Mandaviya tweeted.
"But I have also directed @nppa_india & @CDSCO_INDIA_INF to continuously monitor the availability of Remdesivir in the country. Government of India has also decided to procure 50 lakh vials of Remdesivir to maintain it as a strategic stock for the emergency requirement," he added.
Meanwhile, with 1,73,790 fresh Covid-19 cases recorded in the last 24 hours, India on Saturday reported the lowest single-day Covid-19 rise in 45 days, maintaining the ongoing declining trend, according to the Union health ministry. Active cases in the country fell to 22,28,724 with active cases decreasing by 1,14,428 in the last 24 hours.
(With inputs from agencies)
